In this study, a commercially available human serum sample was used, with the addition of interfering biomarkers such as interleukin‐1β (IL‐1β), TNF‐α, and C‐reactive protein (CRP)—all relevant to IBD—to simulate the serum composition of IBD patients.155. This evidence concerns the gene IL1B and inflammatory bowel disease.